Mirza MR, Benigno B, Dorum A, Mahner S, et al. Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial. Gynecol Oncol 2020 Sep 24. pii: S0090-8258(20)33899.
PMID: 32981695